[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Orphazyme A/S ADR (ORPHY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2021	12-2020	12-2019
Cash Flows From Operating Activities
Net Income	-99,682	-97,013	N/A
Depreciation Amortization	2,882	797	N/A
Other Working Capital	-148	6,551	N/A
Other Operating Activity	1,080	7,079	0
Operating Cash Flow	$-95,869	$-82,586	$N/A

Cash Flows From Investing Activities
PPE Investments	151	-362	N/A
Purchase Sale Intangibles	-144	-419	N/A
Other Investing Activity	-144	-419	0
Investing Cash Flow	$7	$-782	$N/A

Cash Flows From Financing Activities
Debt Repayment	-4,082	-1,614	N/A
Common Stock Issued	74	196,216	N/A
Other Financing Activity	-820	-16,979	0
Financing Cash Flow	$-4,828	$177,623	$N/A

Exchange Rate Effect	1,304	-1,824	N/A
Beginning Cash Position	115,654	18,934	N/A
End Cash Position	16,269	111,366	N/A
Net Cash Flow	$-99,386	$92,432	$N/A

Free Cash Flow
Operating Cash Flow	-95,869	-82,586	N/A
Capital Expenditure	-15	-362	N/A
Free Cash Flow	-95,884	-82,949	0